Meanwhile, in vitro experiments confirmed that CRAMP can mediate autocrine signaling to promote M-CSF and monocyte chemotactic protein (MCP) 1 overexpressing in TRAMP-C1 cells (prostate cancer cell lines without CRAMP expression) to regulate macrophage differentiation to M2 by activating STAT3 [70]. The gene discussed is CAMP; the disease is prostate cancer.